All Pharma News
Novartis takes Gilenya patent case to Supreme Court

Novartis takes Gilenya patent case to Supreme Court
FIERCE PHARMA
25 Jan 2023
Share Share
Generic Drugmaker Asks Justices to Lift Pause on Gilenya Ruling

Generic Drugmaker Asks Justices to Lift Pause on Gilenya Ruling
BLOOMBERG
05 Oct 2022
Share Share
Novartis beats appeal over MS drug patent, keeping generic at bay

Novartis beats appeal over MS drug patent, keeping generic at bay
B. Britian PRESS RELEASE
04 Jan 2022
Share Share
HEC Pharm Group`s Generic Fingolimod Hydrochloride Receives Approval In US

HEC Pharm Group`s Generic Fingolimod Hydrochloride Receives Approval In US
FDA
16 Nov 2021
Share Share
Hec Pharm`s Generic Fingolimod Hydrochloride Receives Tentative Approval in US

Hec Pharm`s Generic Fingolimod Hydrochloride Receives Tentative Approval in US
FDA
26 May 2021
Share Share
Hec Pharm`s Generic Ticagrelor Receives Approval in US

Hec Pharm`s Generic Ticagrelor Receives Approval in US
FDA
07 Apr 2020
Share Share
HEC Pharm`s Generic Fingolimod Hydrochloride Receives Approval In Us

HEC Pharm`s Generic Fingolimod Hydrochloride Receives Approval In Us
FDA
11 Dec 2019
Share Share
FDA greenlights generics of Novartis` $3B MS star Gilenya amid legal fight

FDA greenlights generics of Novartis` $3B MS star Gilenya amid legal fight
Arlene Weintraub FIERCE PHARMA
07 Dec 2019
Share Share
Lannett enters new insulin glargine deal with HEC

Lannett enters new insulin glargine deal with HEC
Jason Aycock SEEKING Alpha
26 Nov 2019
Share Share
111 to establish healthcare retail channel with HEC

111 to establish healthcare retail channel with HEC
BIOSPECTRUM ASIA
15 Nov 2019
Share Share